The inhibition of CSF1R via PLX3397 inhibitor has shown a significant effect on the tumor microenvironment, as CSF1R plays a key role in the recruitment and differentiation of monocytes into TAMs that contribute to melanoma progression [155]. Here, CSF1R is linked to melanoma.